Navigation Links
Europe-wide investment in lipid research will help tackle disease, says new report

Leading scientists today called for Europe to invest more funds into the study of lipids the 'fatty' molecules that play a crucial role in the function of human cells and which are implicated in a range of diseases from obesity and diabetes to Alzheimer's.

Common lipids such as cholesterol are known to play an important part in the normal functioning of cells and tissues, but human cells contain thousands of different lipids which are also vital for functions that include storing energy, maintaining the structure of the cell and sending biochemical signals. Scientists are discovering that if the biochemical pathways that regulate the metabolism and transport of these lipids become disturbed, this can result in disease.

A report* published today by the European Science Foundation (ESF) urges greater cooperation among researchers and more investment in the field of 'lipidomics' the term given to the identification and analysis of the full complement of lipids in cells, tissues and body fluids, together with associated molecular structures such as enzymes and genes. The document is the output of a science policy activity led by the European Medical Research Councils (EMRC), the medical section within ESF.

The ESF science policy briefing document, drawn up by an international panel of experts led by Professor Gerrit van Meer of Utrecht University in The Netherlands and Professor Friedrich Spener of the University of Graz in Austria, says that the study of lipids has been largely neglected because until recently technology did not exist to analyse this complex class of molecules comprehensively. However, the application of an analytical technique called mass spectrometry now allows large numbers of lipids to be analysed rapidly. "This remarkable technological breakthrough will make it possible to better understand the cellular machineries that are responsible for producing and storing energy in cells, for the transport across and between cell membranes and for the signalling in and out of cells to name but a few examples," the report states.

A concerted research effort in lipidomics would help shed light on conditions ranging from obesity and heart disease to cancer and Alzheimer's, the report says, while pointing out that the number of European researchers with expertise in lipidomics is low and that increased funding is needed to help Europe to catch up with the level of research in countries such as Japan and the US.

The science policy briefing makes several key recommendations that would boost lipidomics research in Europe:

  • Investment in research programmes aimed at training biomedical scientists in lipid-related fields
  • Investment in further development of technologies for studying lipids, while establishing and maintaining strong links between technology developers and researchers
  • Development of a strong, coordinated and interdisciplinary research effort across Europe to understand lipid function and the roles of lipids in health and disease
  • Integration of European lipid databases and the facilitation of their communication with other databases worldwide. This would allow the 'holistic' interpretation of lipid data and provide a greater understanding of the role of lipids in health and disease.

Professor van Meer said, "Lipidomics not only involves the study of lipids, but it also involves enzymes, transporters, genes, proteins, and their biophysics. The challenge is to unite all these different datasets and bring them together with disease pathology in one concentrated database." Such an approach would provide invaluable new insights into diagnosing, monitoring and even curing disease, Professor van Meer added.


Contact: Professor Gerrit van Meer
European Science Foundation

Related biology news :

1. Sanitation investment in poor countries would yield $9-to-1 benefits in productivity, health: UN
2. New genetic variants associated with lipid levels, risk for coronary artery disease
3. Story ideas from the Journal of Lipid Research
4. Lipids in the brain an important factor for Alzheimers disease?
5. Story ideas from the Journal of Lipid Research
6. Powerful integration of lipid metabolic profiling with gene expression analysis
7. Chemists get grip on slippery lipids
8. Story ideas from the Journal of Lipid Research
9. Stem cell researchers give old muscle new pep
10. UT Southwestern researchers create molecule that nudges nerve stem cells to mature
11. Growing use of nanomaterials spurs research to investigate possible downsides
Post Your Comments:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: